Differential effects of UTP, ATP, and adenosine on ciliary activity of human nasal epithelial cells.

The purinergic regulation of ciliary activity was studied using small, continuously superfused explants of human nasal epithelium. The P2Y(2) purinoceptor (P2Y(2)-R) was identified as the major purinoceptor regulating ciliary beat frequency (CBF); UTP (EC(50) = 4.7 microM), ATP, and adenosine-5'-O-(3-thiotriphosphate) elicited similar maximal responses, approximately twofold over baseline. ATP, however, elicited a post-peak sustained plateau in CBF (1.83 +/- 0.1-fold), whereas the post-peak CBF response to UTP declined over 15 min to a low-level plateau (1.36 +/- 0.16-fold). UDP also stimulated ciliary beating, probably via P2Y(6)-R, with a maximal effect approximately one-half that elicited by P2Y(2)-R stimulation. Not indicated were P2Y(1)-R-, P2Y(4)-R-, or P2Y(11)-R-mediated effects. A(2B)-receptor agonists elicited sustained responses in CBF approximately equal to those from UTP/ATP [5'-(N-ethylcarboxamido)adenosine, EC(50) = 0.09 microM; adenosine, EC(50) = 0.7 microM]. Surprisingly, ADP elicited a sustained stimulation in CBF. The ADP effect and the post-peak sustained portion of the ATP response in CBF were inhibited by the A(2)-R antagonist 8-(p-sulfophenyl)theophylline. Hence, ATP affects ciliary activity through P2Y(2)-R and, after an apparent ectohydrolysis to adenosine, through A(2B)AR.

[1]  V. Cressman,et al.  Effect of Loss of P2Y2 Receptor Gene Expression on Nucleotide Regulation of Murine Epithelial Cl−Transport* , 1999, The Journal of Biological Chemistry.

[2]  W. Watt,et al.  UDP activates a mucosal-restricted receptor on human nasal epithelial cells that is distinct from the P2Y2 receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[3]  G. Stiles,et al.  The role of receptor structure in determining adenosine receptor activity. , 2000, Pharmacology & therapeutics.

[4]  T. Akiyama,et al.  Nucleotide-induced mucin release from primary hamster tracheal surface epithelial cells involves the P2u purinoceptor. , 1996, The European respiratory journal.

[5]  J. T. Turner,et al.  Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  T. K. Harden,et al.  P2-purinergic receptors: subtype-associated signaling responses and structure. , 1995, Annual review of pharmacology and toxicology.

[7]  Harden Tk,et al.  Release of ATP and UTP from astrocytoma cells. , 1999 .

[8]  R. Boucher,et al.  Role of CNP in human airways: cGMP-mediated stimulation of ciliary beat frequency. , 1995, The American journal of physiology.

[9]  M. Knowles,et al.  Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. , 1991, The New England journal of medicine.

[10]  J. Mackey,et al.  Nucleoside transporters: molecular biology and implications for therapeutic development. , 1999, Molecular medicine today.

[11]  W. Watt,et al.  Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor. , 1996, Molecular Pharmacology.

[12]  H. B. Stoner,et al.  Biological actions of the adenine nucleotides , 1950 .

[13]  A. Korngreen,et al.  Purinergic stimulation of rabbit ciliated airway epithelia: control by multiple calcium sources. , 1996, The Journal of physiology.

[14]  T. K. Harden,et al.  Agonist action of adenosine triphosphates at the human P2Y1 receptor. , 1998, Molecular pharmacology.

[15]  J. Boeynaems,et al.  Pharmacological characterization of the human P2Y11 receptor , 1999, British journal of pharmacology.

[16]  E. Lazarowski,et al.  Release of ATP and UTP from astrocytoma cells. , 1999, Progress in brain research.

[17]  J. Boeynaems,et al.  Advances in signalling by extracellular nucleotides. the role and transduction mechanisms of P2Y receptors. , 2000, Cellular signalling.

[18]  I Biaggioni,et al.  Adenosine A2B receptors. , 1997, Pharmacological reviews.

[19]  R. Boucher,et al.  Adenosine receptors on human airway epithelia and their relationship to chloride secretion , 1992, British journal of pharmacology.

[20]  M. K. James,et al.  Aerosolization of P2Y(2)-receptor agonists enhances mucociliary clearance in sheep. , 1999, Journal of applied physiology.

[21]  P. Cesare,et al.  ATP, P2X receptors and pain pathways. , 2000, Journal of the autonomic nervous system.

[22]  M. Kondo,et al.  Adenosine-mediated cyclic AMP-dependent inhibition of ciliary activity in rabbit tracheal epithelium. , 1989, The American review of respiratory disease.

[23]  S. Donaldson,et al.  Therapeutic Applications for Nucleotides in Lung Disease , 1998 .

[24]  G. Burnstock,et al.  Molecular cloning and characterization of rat P2Y4 nucleotide receptor , 1998, British journal of pharmacology.

[25]  P. Forsythe,et al.  Adenosine, mast cells and asthma , 1999, Inflammation Research.

[26]  M. Knowles,et al.  Effect of uridine 5'-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis. , 1996, American journal of respiratory and critical care medicine.

[27]  T. K. Harden,et al.  Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5'-nucleotide receptor in human airway epithelial cells. , 1991, Molecular pharmacology.

[28]  A. Collett,et al.  Effect of luminal nucleotides on Cl– secretion and Na+ absorption in distal bronchi , 1999, Pflügers Archiv.

[29]  H Zimmermann,et al.  Extracellular metabolism of nucleotides in the nervous system. , 1996, Journal of autonomic pharmacology.

[30]  T. K. Harden,et al.  Identification of competitive antagonists of the P2Y1 receptor. , 1996, Molecular pharmacology.

[31]  D. Yeates,et al.  Luminal purinergic regulatory mechanisms of tracheal ciliary beat frequency. , 1992, American journal of respiratory cell and molecular biology.

[32]  J. Hescheler,et al.  Mechanical strain-induced Ca(2+) waves are propagated via ATP release and purinergic receptor activation. , 2000, American journal of physiology. Cell physiology.

[33]  M. Parmentier,et al.  Cloning, functional expression and tissue distribution of the human P2Y6 receptor. , 1996, Biochemical and biophysical research communications.

[34]  Y. Okada,et al.  Cell surface measurements of ATP release from single pancreatic β cells using a novel biosensor technique , 1998, Pflügers Archiv.

[35]  P. Insel,et al.  Cellular Release of and Response to ATP as Key Determinants of the Set-Point of Signal Transduction Pathways* , 2000, The Journal of Biological Chemistry.

[36]  Marc Parmentier,et al.  Cloning of a Human Purinergic P2Y Receptor Coupled to Phospholipase C and Adenylyl Cyclase* , 1997, The Journal of Biological Chemistry.

[37]  L. Abdullah,et al.  Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. , 1996, American journal of respiratory cell and molecular biology.

[38]  M. Welsh,et al.  Mucosal adenosine stimulates chloride secretion in canine tracheal epithelium. , 1986, The American journal of physiology.

[39]  K. Dezaki,et al.  Receptor-mediated facilitation of cell volume regulation by swelling-induced ATP release in human epithelial cells. , 2000, The Japanese journal of physiology.

[40]  W. Watt,et al.  Cystic Fibrosis Transmembrane Regulator-independent Release of ATP , 1998, The Journal of Biological Chemistry.

[41]  C. Shin,et al.  Airway goblet cell mucin: its structure and regulation of secretion. , 1997, The European respiratory journal.

[42]  S. Randell,et al.  Coordinated clearance of periciliary liquid and mucus from airway surfaces. , 1998, The Journal of clinical investigation.

[43]  J. Boeynaems,et al.  Slow desensitization of the human P2Y6 receptor. , 1997, European journal of pharmacology.

[44]  H. Zimmermann,et al.  Ecto-nucleotidases--molecular structures, catalytic properties, and functional roles in the nervous system. , 1999, Progress in brain research.

[45]  R. Boucher,et al.  Constitutive Release of ATP and Evidence for Major Contribution of Ecto-nucleotide Pyrophosphatase and Nucleoside Diphosphokinase to Extracellular Nucleotide Concentrations* , 2000, The Journal of Biological Chemistry.

[46]  G. Burnstock,et al.  Purinergic signalling: pathophysiological roles. , 1998, Japanese journal of pharmacology.

[47]  R. Boucher,et al.  Regulation of transepithelial ion transport and intracellular calcium by extracellular ATP in human normal and cystic fibrosis airway epithelium , 1991, British journal of pharmacology.

[48]  R. Nicholas,et al.  ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor. , 2000, Molecular pharmacology.

[49]  D. Erlinge.  Extracellular ATP: a growth factor for vascular smooth muscle cells. , 1998, General pharmacology.

[50]  C. W. Davis.  Goblet Cells: Physiology and Pharmacology , 1997 .

[51]  M. Knowles,et al.  Pharmacologic treatment of abnormal ion transport in the airway epithelium in cystic fibrosis. , 1995, Chest.

[52]  R. North,et al.  Pharmacology of cloned P2X receptors. , 2000, Annual review of pharmacology and toxicology.

[53]  J. Gromada,et al.  Multiple sites of purinergic control of insulin secretion in mouse pancreatic beta-cells. , 1999, Diabetes.

[54]  R. Boucher,et al.  Multiple modes of regulation of airway epithelial chloride secretion by extracellular ATP. , 1994, The American journal of physiology.

[55]  A. Korngreen,et al.  Extracellular sodium regulates airway ciliary motility by inhibiting a P2X receptor , 1999, Nature.

[56]  M. Parmentier,et al.  Expression of P2Y receptors in cell lines derived from the human lung , 1999, British journal of pharmacology.

[57]  R. Boucher.  Human airway ion transport. Part one. , 1994, American journal of respiratory and critical care medicine.

[58]  R. Boucher,et al.  Human airway ion transport. Part two. , 1994, American journal of respiratory and critical care medicine.

[59]  M. King,et al.  Effect of aerosolized uridine-5'-triphosphate on airway clearance with cough in patients with primary ciliary dyskinesia. , 1999, American journal of respiratory and critical care medicine.

[60]  S H Randell,et al.  P2u purinoceptor regulation of mucin secretion in SPOC1 cells, a goblet cell line from the airways. , 1996, The Biochemical journal.

[61]  R. Boucher,et al.  Metabolism of extracellular nucleotides in human airways by a multienzyme system , 2001 .

[62]  G Burnstock,et al.  Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.

[63]  G Burnstock,et al.  P2X receptors in sensory neurones. , 2000, British journal of anaesthesia.

[64]  W. Watt,et al.  Pharmacological selectivity of the cloned human P2U‐purinoceptor: potent activation by diadenosine tetraphosphate , 1995, British journal of pharmacology.

[65]  M J Sanderson,et al.  Intercellular propagation of calcium waves mediated by inositol trisphosphate. , 1992, Science.

[66]  R. Evans,et al.  P2 purinoceptor‐mediated control of rat cerebral (pial) microvasculature; contribution of P2X and P2Y receptors , 2000, The Journal of physiology.

[67]  W. Watt,et al.  Nucleotide-regulated Calcium Signaling in Lung Fibroblasts and Epithelial Cells from Normal and P2Y2 Receptor (−/−) Mice* , 1999, The Journal of Biological Chemistry.

[68]  M. Knowles,et al.  Pharmacologic modulation of salt and water in the airway epithelium in cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.

[69]  T. Steinberg,et al.  Cell to Cell Communication in Response to Mechanical Stress via Bilateral Release of Atp and Utp in Polarized Epithelia , 2000, The Journal of cell biology.

[70]  R. Quinn,et al.  Adenosine receptors: new opportunities for future drugs. , 1998, Bioorganic & medicinal chemistry.

[71]  M. Kaliner,et al.  Mast cells and asthma , 1991 .